Journal of Medicinal Chemistry · 2023 · 50 citations · 14 references
Life SciencesBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructural BiologyEnzyme FunctionLigand BindingProtein DegradationProtein DesignProtein StructureStructural MotifsBindersDe Novo Protein Binder DesignE3 Ubiquitin Ligase Substrate RecognitionLigase InhibitorsOptimization Of Drug-like PropertiesProteasome-mediated DegradationProtein TargetsTargeted Protein Degradation
Modulating the chemical composition of cereblon (CRBN) binders is a critical step in the optimization process of protein degraders that seek to hijack the function of this E3 ligase. Small structural changes can have profound impacts on the overall profile of these compounds, including depth of on-target degradation, neosubstrate degradation selectivity, as well as other drug-like properties. Herein, we report the design and synthesis of a series of novel CRBN binding moieties. These CRBN binders were evaluated for CRBN binding and degradation of common neosubstrates Aiolos and GSPT1. A selection of these binders was employed for an exploratory matrix of heterobifunctional molecules, targeting CRBN-mediated degradation of the androgen receptor.
14
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran, Samedy Ouk, Nicola J. Clegg et al. · Science · 2009 · 2.3K citations · Full text
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito, Hideki Ando, Takayuki Suzuki et al. · Science · 2010 · 2.1K citations
Site-selective arene C-H amination via photoredox catalysis
Nathan A. Romero, Kaila A. Margrey, Nicholas E. S. Tay et al. · Science · 2015 · 939 citations
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Mary E. Matyskiela, Gang Lu, Takumi Ito et al. · Nature · 2016 · 670 citations